Skip to content

The Effect of Citrus Aurantium distillate on Anxiety and Sleep Disorder in mothers with neonate admitted to neonatal intensive care unit

Comparison of the effectiveness of Citrus Aurantium distillate on anxiety and sleep disorders in mothers with infants

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20201209049666N1
Enrollment
60
Registered
2021-04-15
Start date
2021-05-03
Completion date
Unknown
Last updated
2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Sleep Disorders. Condition 2: Anxiety. Other sleep disorders Anxiety disorder due to known physiological condition

Interventions

Intervention 1: Intervention group: Citrus Aurantium distillate 500 mg, twice daily + Fluoxetine 20 mg daily for 7 days. Intervention 2: Control group: Fluoxetine 20 mg daily plus placebo (Water + su

Sponsors

Babol University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Having literacy No history of disease 7 days have passed since the baby was admitted Score 43 or higher General Sleep Disorder Lack of sensitivity to plants No history of premature infants Not having various problems in pregnancy such as heart disease and ...

Exclusion criteria

Exclusion criteria: Infant hospitalization less than 14 days in the neonatal intensive care unit The mother's unwillingness to continue participating in the study Occurrence of unpleasant events for the mother Maternal sensitivity to orange spring sweat

Design outcomes

Primary

MeasureTime frame
The effect of Citrus Aurantium Sweat on anxiety in mothers with infants. Timepoint: Before the intervention and after the last day of the intervention. Method of measurement: The State-Trait Anxiet Inventory.;The effect of orange spring sweat on the rate of sleep disorders in mothers with infants. Timepoint: Before the intervention and after the last day of the intervention. Method of measurement: General Sleep Disturbance Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public Contactzahra Dehgan

Babol University of Medical Sciences

info@mubabol.ac.ir+98 51 4622 5472

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 5, 2026